Journal Information
Vol. 43. Issue S1.
Pages S543-S544 (October 2021)
Share
Share
Download PDF
More article options
Vol. 43. Issue S1.
Pages S543-S544 (October 2021)
Open Access
MAIN BLOOD SERUM METABOLITES RESPONSIBLE FOR THE DISCRIMINATION OF HOSPITALIZED PATIENTS WITH MODERATE SYMPTOMS WITH OR WITHOUT COVID-19
Visits
1474
LG Martinsa, SS Martinsb, ES Bragaa, D Stanisica, SAL Montalvãob, LQ Silvab, SC Huberb, T Diazc, C Wroclawskid, CC Filhod, L Tasica, JM Annichino-Bizzacchib
a Laboratório de Química Biológica, Departamento de Química Orgânica, Instituto de Química, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil
b Laboratório de Hemostasia e Trombose, Centro de Hematologia e Hemoterapia, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil
c Hospital Municipal de Campanha (HMCamp) do Anhembi, São Paulo, SP, Brazil
d Centro de Hemostasia e Trombose, Hospital Sírio-Libanês, São Paulo, SP, Brazil
This item has received

Under a Creative Commons license
Article information
Special issue
This article is part of special issue:
Vol. 43. Issue S1
More info
Introduction

The variation in human blood serum metabolites resulting from an infection can assist in understanding mechanisms of pathogen action and body response and improve diagnosis.

Aim

To map serum signatures of hospitalized symptomatic patients, positive or negative to SARS-CoV-2.

Methods

Patients (n = 64) admitted to Anhembi Field Municipal Hospital, a hospital set up for initial care to patients with moderate symptoms, were analyzed being discriminated in positive (n = 32) or negative patients. Age and gender were matched to ensure homogeneity in the basal metabolic rates. Three Nuclear Magnetic Resonance (NMR) data set were recorded on Bruker AVANCE III 600 MHz spectrometer for serum samples analyzed in MetaboAnalyst 5.0 software platform.

Results and discussion

The mean age of groups was 54.92 ±12.41 and 54.30 ±12.15, for positive and negative patients, divided in 16 female and 16 male. The ethnicity was 56.2% vs 46.8% caucasian, 34.3% mixed race in both groups, and 9.3% 12.5% vs black in positive and negative groups, respectively. BMI was 24 ±6.93 vs 33.5 ±7.85 in comparison to positive and negative patients, respectively. In both groups 50% of patients presented alveolar infiltrate.  Although the groups were not paired by comorbidities, they were homogeneous ensuring that the metabolic variation is due to COVID-19 as similar percentage of patients with arterial hypertension, diabetes and dyslipidemia. Clinical symptoms were also remarkably similar between the groups in relation to: fever, dry cough, dyspnea and myalgia. The Partial Least Squares - Discriminant Analysis (PLS-DA) performed onto noesy1d data discriminated positively from negative patients. Also, it covered lower variance. Combining NMR techniques, it was possible to depict the main metabolites that distinguished the COVID-19 signatures. Alanine, glucose, cholesterol, and glutamine were increased, and lactate decreased in COVID-19.

Conclusion

These results suggest NMR as an excellent tool to differentiate hospitalized patients with moderate symptoms as COVID-19 positive or negative. The Ethics Research Committee of the University of Campinas approved all of the experimental procedures, and all individuals signed the informed consent form.

Full text is only aviable in PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools